CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
hypoxiaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06264193
NCT06264193N/ACompleted

The Effects of Live High-train Low on EPO, VEGF, and Hematological Variables in Elite Rowers

Poznan University of Physical Education·interventional·Posted Feb 16, 2024·Updated Jan 17, 2025

In Brief

A clinical study evaluating hypoxia for Hypoxia. Completed, enrolled 13 participants.

Detailed Summary

The response to hypoxia is very individual and epending on many aspects, such as the type of training, duration, intensity, or hypoxic stimulus, hypoxia affects the athlete in various ways. The results of this study have shown that 18 days of the LH-TL method does not significantly increase the level of EPO and VEGF in rowers. However, reticulocytes, immature red blood cells, have shown significant differences after 18-d LH-TL between groups. Further research should be carried out to investigate an optimal hypoxic dose and time, which will raise EPO, VEGF, and morphology variables.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoxia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 16, 2024
Enrollment StartNov 30, 2014
Primary CompletionDec 21, 2014
TodayJul 2, 2026
Enrollment to primary: 21 daysPosted 2.4 years ago

Interventions

hypoxiaother

The athletes were living in hypoxic rooms, and training was carried out on lowlands.